NewAmsterdam Pharma Company
NAMS
#4541
Rank
โ‚น227.12 B
Marketcap
โ‚น1,894
Share price
0.85%
Change (1 day)
-41.45%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -โ‚น21.78 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are โ‚น25.93 Million. In 2025 the company made an earning of -โ‚น21.23 Billion, an increase over its 2024 earnings that were of -โ‚น23.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น21.78 Billion2.63%
2025 -โ‚น21.23 Billion-7.81%
2024 -โ‚น23.02 Billion38.38%
2023 -โ‚น16.64 Billion